Qiming Venture Partners

Qiming Venture Partners is a prominent venture capital firm based in Shanghai, China, with additional offices in Beijing, Suzhou, and Hong Kong. Founded in 2006, the firm specializes in investing in early to growth-stage companies across various sectors, including healthcare, information technology, consumer products, media, and clean technology. Qiming has established itself as a leading investment firm in China, managing multiple funds with over $1 billion in assets. The firm focuses on supporting innovative entrepreneurs and companies that demonstrate high growth potential, particularly in the technology and healthcare landscapes. Through its strategic investments, Qiming aims to foster the development of new business models and technologies, contributing to the dynamic entrepreneurial ecosystem in China.

Zhang Ao

Executive Director

Artavazd Arumov Ph.D

Principal

Ryan Baker

CFO

Cyrus Chan

Associate

Kan Chen

Partner

Liwen Chen

Associate

Nan Chen

Principal

David Chu

Partner

Phil DiGiacomo

Principal

Anna French

Managing Partner

Yuxin Fu

Associate

Jinda Gao

Principal

Kuantai Yeh

Partner

Robert Headley

Partner

Maykin Ho Ph.D

Venture Partner

William Hu

Managing Partner

Duane Kuang

Founding Managing Partner

Nisa Leung

Managing Partner

Lisa Li

Investor

Dingzheng Li

Vice President

Jing Liu

Associate

Chang Liu

Associate

Bin Liu

Associate

Biao Lu

Associate

Shuo Mao

Principal

Will Mcconnell

Principal

Mark McDade

Co-Founder and Managing Partner

Gary Rieschel

Founder and Managing Partner

Motao Sun

Associate

Amy Tang

Venture Partner

Yi Tang

Principal

Shiyu Wang

Partner

Shiyu Wang

Partner

Bonnie Wang

Principal

Rachel Wang

Venture Partner

Xin Wang

Investor

James Wang

Venture Partner

Gillian Xu

RMB funds CFO

Kuantai Yeh

Partner

Peter (Ming) Yin

Principal, Cleantech

Janet Yu Ph.D

Partner

Liang Yuyu

Managing Partner

Oscar Zhang

Principal

Yafeng Zhou

Associate

Alex Zhou

Managing Partner

Zhiyuan Zhou

Investor

Zhifeng Zhou

Managing Partner

Yiqing Zhu

Associate

Jing-Shan Hu Ph.D

Venture Partner of Healthcare

Phillip DiGiacomo Ph.D

Principal

Past deals in Late Venture Stage

Ark Biosciences

Series D in 2022
Ark Biosciences Inc. is a biopharmaceutical company based in Shanghai, China, focused on discovering and developing therapeutics for unmet medical needs, particularly in respiratory viral infections and viral hepatitis. Founded in 2013, the company is dedicated to addressing global health challenges with its innovative products, which include AK0701 for chronic obstructive pulmonary disease, AK0529 for respiratory syncytial virus, AK0612 for influenza, and AK0705 and AK0706 for hepatitis B. Ark Biosciences aims to establish itself as a leader in antiviral drug development through a commitment to scientific excellence and innovation.

InSilico Medicine

Series D in 2022
InSilico Medicine, Inc. is an artificial intelligence company focused on drug discovery, biomarker development, and aging research. Founded in 2014 and headquartered in Baltimore, Maryland, the company employs advanced AI technologies, including deep learning and generative adversarial networks, to create novel molecular structures for diseases with known and unknown targets. Its comprehensive platform covers all stages of drug development, from discovery to clinical trials. Key initiatives include Pharma.AI, which offers machine learning services to various industries, and Young.AI, which predicts biological age. InSilico Medicine also engages in internal drug discovery programs targeting conditions such as cancer, Parkinson's Disease, and age-related disorders. Additionally, the company has partnered with Life Extension to develop nutraceutical products using its bioinformatics and deep learning techniques. Through its innovative solutions, InSilico Medicine aims to enhance personalized healthcare and mitigate the effects of aging.

Shanzhen

Series D in 2021
Shanzhen is a health service platform focused on addressing the physical health and pension needs of individuals born in the 1980s and 1990s. The company provides affordable regular health checkups and personalized health management plans, alongside insurance options. Additionally, Shanzhen offers a range of medical examination services and data finance products aimed at tackling the challenges posed by an aging population and the rising incidence of chronic diseases. By prioritizing the well-being of elderly patients, Shanzhen aims to enhance their quality of life, enabling them to lead happier and healthier lives.

Petkit

Series D in 2021
Shanghai PETKIT Network Technology Co., Ltd., founded in 2013, specializes in developing and manufacturing innovative pet care products. Based in Shanghai, China, the company offers a diverse range of smart devices designed to enhance the health and well-being of pets. Its product lineup includes smart feeders, antibacterial bowls, drinking fountains, and pet monitoring devices that track activity levels, calorie consumption, and overall health. Additionally, Petkit provides a mobile application that integrates with its smart devices, allowing pet owners to monitor their pets' behaviors and health metrics conveniently. By combining technology with pet care, Petkit aims to simplify pet management for owners while ensuring the welfare of their animals.

NEIWAI

Series D in 2021
NEIWAI is a mid-to-high-end underwear brand founded in Shanghai in 2012, dedicated to providing comfortable clothing that respects the feelings of women. The company emphasizes a design philosophy that harmonizes comfort, function, and beauty, resulting in a diverse range of products suitable for various daily activities, including home and sports. Over the past five years, NEIWAI has served more than 200,000 female customers, reflecting its commitment to meeting the needs of its clientele. By focusing on the comfort of close-fitting clothing, NEIWAI aims to enhance the everyday experiences of its customers through thoughtfully designed underwear.

Insight Lifetech

Series D in 2021
Insight Lifetech Co., Ltd. is a Chinese company focused on the development and manufacturing of medical equipment for heart intervention. The firm specializes in creating high-quality devices designed to enhance the diagnosis and therapy of cardiovascular diseases. By utilizing innovative technologies, Insight Lifetech aims to provide reliable precision in medical treatments, ultimately enabling healthcare professionals to save and improve patients' lives.

Xiaoe Tech

Series D in 2021
Shenzhen Xiaoe Network Technology Co., Ltd. specializes in software development for education and content payment technologies. Established in 2016 and based in Shenzhen, China, the company offers a range of products, including enterprise internal training solutions, PaaS cloud services, and SaaS tools for media companies and content creators. Xiaoe Tech focuses on enabling knowledge monetization through its platforms, providing services such as content traffic distribution, business academies, and conference systems. Its offerings assist content entrepreneurs and educational institutions in managing customer relationships and enhancing operational efficiency. By integrating tools, data, and resources, Xiaoe Tech supports various industries in achieving effective brand communication, traffic growth, and comprehensive business monetization.

LetsGetChecked

Series D in 2021
LetsGetChecked is an at-home health testing platform that connects customers to regulated laboratory testing to better manage and control one's individual health. LetsGetChecked is making healthcare and diagnostics open and patient-led, empowering people to use technology in a simple yet powerful way. This offers consumers greater control over their individual health. LetsGetChecked is headquartered in New York, NY, with tests covering general wellness, sexual health, women's health and men's health, and is available nationwide, as well as in Canada and Europe.

Hesai Technology

Series D in 2021
Hesai Technology specializes in the design and manufacture of laser sensors, particularly focusing on LiDAR technology. Founded in 2013 and headquartered in Shanghai, China, the company provides advanced sensing solutions for autonomous vehicles and various robotic applications, including last-mile delivery and industrial automation. Their products also include gas leak detection systems, which help monitor mixed gas compositions and identify hazardous leaks in the natural gas industry. With a strong emphasis on innovation, Hesai Technology supports the development of advanced driver assistance systems (ADAS) and autonomous mobility solutions, serving a diverse range of industries by enhancing safety and efficiency through smart sensing technology.

IntoCare

Series D in 2021
IntoCare is a high-tech company focused on the development of advanced medical devices for surgical procedures. The company specializes in powered surgical staplers, offering both reusable and disposable stapler handles. IntoCare aims to enhance surgical practices by providing reliable, intelligent, and user-friendly instruments. Through its research and development efforts, the company seeks to advance the field of surgical technology and support the marketing of nonpharmaceutical interventions, ensuring that healthcare professionals have access to innovative tools that improve patient outcomes.

ET Healthcare

Series G in 2021
ET Healthcare, Inc. is an in vitro diagnostics company that specializes in manufacturing central laboratory analyzers for both inpatient and outpatient testing in various medical settings, including hospitals and clinics. The company has developed the Pylon Immunochemistry System, an integrated turnkey solution that addresses the immunodiagnostics needs across several areas, such as inflammation, cardiac function, fertility, infectious diseases, and tumors. Additionally, the Pylon BNP Immunoassay aids in managing heart failure by measuring B-type natriuretic peptide levels in plasma. ET Healthcare’s offerings include a variety of immunoassays for cardiac markers, blood clots, and other health conditions, facilitating simplified blood analysis for physicians. Based in Palo Alto, California, the company also has offices in Shanghai, China, and operates manufacturing facilities in Suzhou, China.

Unisound

Series D in 2021
Beijing Unisound Information Technology Co., Ltd. offers internet of things artificial intelligence services for home furnishing, medical, finance, education, transportation, automobiles, real estate, and other fields. It provides industry service robot, smart home, smart car, smart medical, smart education, early childhood education, and UniToy program solutions. The company was founded in 2012 and is based in Beijing, China with additional offices in Shanghai, Xiamen, and Shenzhen, China.

Delta Medical

Series E in 2021
Beijing Delta Medical Co., Ltd. specializes in the design and manufacture of orthopedic surgical instruments and rehabilitation products. The company offers a range of products, including shoulder arthroscopic instruments, various types of suture anchors, instruments for anterior and posterior cruciate ligament reconstruction, interference screws, and shaver systems. In addition to its surgical instruments, Delta Medical provides sports rehabilitation services. The company is headquartered in Beijing, China, and focuses on delivering innovative solutions in sports medicine.

XSKY Data Technology

Series E in 2021
XSky (Beijing) Data Technology Co., Ltd. is a Chinese company specializing in software-defined infrastructure products and services. It offers a range of storage solutions, including XCBS for cloud storage, XEBS for block storage, XEUS for unified storage, XEOS for object storage, and XEDP as a unified data platform. The company also provides software-defined storage solutions with its XSCALER series. XSky serves various sectors, including finance, healthcare, education, telecommunications, and energy, catering to enterprises, government agencies, and media networks. In addition to its product offerings, XSky is a significant contributor to the open-source storage system Ceph and is recognized as a leading partner of Red Hat in China. The company collaborates with major IT firms like Intel and Dell to enhance its technology and solutions, focusing on scalable and future-ready storage options.

Miaoshou Doctor

Series E in 2021
Miaoshou Doctor is a healthcare service platform founded in 2015 by Tao He and Daoliang Han, based in Beijing. The platform facilitates communication between healthcare professionals and patients, focusing on the management of post-diagnosis outcomes. It enables doctors to actively follow up with patients through additional counseling and prescriptions, enhancing the overall patient care experience. By providing tools for effective interaction, Miaoshou Doctor aims to improve health management for both patients and doctors.

Erwan Technology

Series E in 2021
Erwan Technology is a China-based wealth management education platform.

Erwan Technology

Series D in 2021
Erwan Technology is a China-based wealth management education platform.

Abbisko Therapeutics

Series D in 2021
Abbisko Therapeutics Co. Ltd. discovers, develop, and manufactures immuno-oncology therapies. It offers ABSK011 and ABSK021, which are molecule inhibitors for treating hepatocellular carcinoma; and CSF1R for the treatment of solid tumors. The company also develops therapeutics for the treatment of cancer, tumor, and diabetes, metabolic diseases, liver diseases, viral infections and CNS diseases. The company was founded in 2016 and is based in is based in Shanghai, China.

Yunyinggu

Series D in 2020
Yunyinggu Technology Co., Ltd. is a Chinese start-up focused on the development and promotion of innovative display technologies aimed at enhancing the performance of flat panel displays. The company has created a proprietary solution recognized for achieving superior pixel density, or high pixels per inch (PPI), which can be utilized across various types of flat panels, including LCD, LED, and OLED displays. By advancing display technology, Yunyinggu seeks to contribute to the evolving landscape of visual performance in consumer electronics.

Asieris Pharmaceuticals

Series D in 2020
Asieris Pharmaceuticals Co. Ltd. is a Chinese biotechnology company established in 2010 and headquartered in Taizhou, China. The company specializes in the research and development of pharmaceutical products aimed at treating tumors and addressing multidrug-resistant infections. Asieris focuses on innovative therapies within the oncology sector and is dedicated to combating the challenges posed by drug-resistant pathogens.

InventisBio

Series D in 2020
InventisBio Inc. is a biotechnology company focused on discovering and developing innovative therapeutics for cancer and metabolic diseases. Founded in 2013 and based in Pudong, China, the company is advancing a pipeline of small molecule drug candidates targeting lung cancer, breast cancer, and gout. Notably, it is developing D-0316, a third-generation EGFR-T790M tyrosine kinase inhibitor, and is exploring combinations of its drugs with other immuno-oncology therapies, such as PD-1 antibodies, for various cancer indications. Co-founded by Dr. Yaolin Wang and a team of scientists with prior experience at major pharmaceutical companies like Merck and Schering-Plough, InventisBio aims to leverage their expertise in oncology and metabolic diseases to bring effective treatments to market.

Delta Medical

Series D in 2020
Beijing Delta Medical Co., Ltd. specializes in the design and manufacture of orthopedic surgical instruments and rehabilitation products. The company offers a range of products, including shoulder arthroscopic instruments, various types of suture anchors, instruments for anterior and posterior cruciate ligament reconstruction, interference screws, and shaver systems. In addition to its surgical instruments, Delta Medical provides sports rehabilitation services. The company is headquartered in Beijing, China, and focuses on delivering innovative solutions in sports medicine.

New Horizon Health

Series E in 2020
New Horizon Health, founded in 2015 and headquartered in Hangzhou, China, specializes in developing advanced technologies for the detection and screening of gastrointestinal cancers, particularly gastric and colorectal cancers. The company offers innovative products based on fecal gene analysis (FIT-DNA) technology, enabling users to conduct at-home tests that identify signs of colon cancer and significant adenomas. This technology facilitates earlier detection of precancerous lesions compared to conventional blood tests. By leveraging big data and artificial intelligence, New Horizon Health enhances its cancer screening solutions, aiming to improve public health outcomes. The company also emphasizes its commitment to making early cancer screening accessible to households, thereby striving to reduce the incidence and mortality associated with cancer.

XSKY Data Technology

Series D in 2020
XSky (Beijing) Data Technology Co., Ltd. is a Chinese company specializing in software-defined infrastructure products and services. It offers a range of storage solutions, including XCBS for cloud storage, XEBS for block storage, XEUS for unified storage, XEOS for object storage, and XEDP as a unified data platform. The company also provides software-defined storage solutions with its XSCALER series. XSky serves various sectors, including finance, healthcare, education, telecommunications, and energy, catering to enterprises, government agencies, and media networks. In addition to its product offerings, XSky is a significant contributor to the open-source storage system Ceph and is recognized as a leading partner of Red Hat in China. The company collaborates with major IT firms like Intel and Dell to enhance its technology and solutions, focusing on scalable and future-ready storage options.

Miaoshou Doctor

Series D in 2020
Miaoshou Doctor is a healthcare service platform founded in 2015 by Tao He and Daoliang Han, based in Beijing. The platform facilitates communication between healthcare professionals and patients, focusing on the management of post-diagnosis outcomes. It enables doctors to actively follow up with patients through additional counseling and prescriptions, enhancing the overall patient care experience. By providing tools for effective interaction, Miaoshou Doctor aims to improve health management for both patients and doctors.

New Horizon Health

Series D in 2020
New Horizon Health, founded in 2015 and headquartered in Hangzhou, China, specializes in developing advanced technologies for the detection and screening of gastrointestinal cancers, particularly gastric and colorectal cancers. The company offers innovative products based on fecal gene analysis (FIT-DNA) technology, enabling users to conduct at-home tests that identify signs of colon cancer and significant adenomas. This technology facilitates earlier detection of precancerous lesions compared to conventional blood tests. By leveraging big data and artificial intelligence, New Horizon Health enhances its cancer screening solutions, aiming to improve public health outcomes. The company also emphasizes its commitment to making early cancer screening accessible to households, thereby striving to reduce the incidence and mortality associated with cancer.

Club Factory

Series D in 2019
Club Factory operates an online shopping platform that facilitates cross-border e-commerce by connecting consumers directly with manufacturers. The company utilizes big data and artificial intelligence to scan the internet for factories selling products on major platforms like Wish, eBay, and Amazon, allowing it to compare prices from multiple sources. This approach enables Club Factory to present customers with the most competitive pricing options. In addition to enhancing the shopping experience for consumers, the platform also offers supply chain management solutions for enterprises, thereby streamlining the process of purchasing goods at lower prices.

Shanzhen

Series D in 2019
Shanzhen is a health service platform focused on addressing the physical health and pension needs of individuals born in the 1980s and 1990s. The company provides affordable regular health checkups and personalized health management plans, alongside insurance options. Additionally, Shanzhen offers a range of medical examination services and data finance products aimed at tackling the challenges posed by an aging population and the rising incidence of chronic diseases. By prioritizing the well-being of elderly patients, Shanzhen aims to enhance their quality of life, enabling them to lead happier and healthier lives.

DST Car

Series D in 2019
DiShangTie Car Rental (Shenzhen) Co., Ltd. is a Shenzhen-based company that specializes in the rental and maintenance of commercial electric vehicles (EVs) for both passenger and cargo transportation in China. Founded in 2015, the company also manufactures electric car charging stations, catering to the growing demand for sustainable transportation solutions. By focusing on the transportation and logistics industry, DiShangTie aims to facilitate the adoption of new energy vehicles in the region.

Bondent Technology

Series D in 2019
Provider of integrated oral medical solutions for oral health and dental industry. The company offers technical training, operation and management consulting services to their clients. The company also involves in the design, development, manufacturing, and sales of oral medical equipment, providing a full fledged ecosystem for the dental and oral health industry.

Mafengwo

Series E in 2019
Beijing Mafengwo Network Technology Co., Ltd. operates a comprehensive travel platform that provides information on both domestic and international travel destinations. Founded in 2006, the company allows users to share their travel experiences through a social networking site, featuring over one million user-generated travel guides and more than five million ratings and reviews. Mafengwo offers a wide range of services, including travel route planning, hotel bookings, and essential travel information such as visa requirements and insurance. The platform also emphasizes user engagement and continuously enhances its features to improve the sharing of travel-related content. With a core product encompassing a vast array of global destinations, Mafengwo has achieved over 100 million downloads of its travel guides and serves millions of users annually. The company has integrated various booking services, partnering with established platforms to streamline the travel planning process. Based in Beijing, Mafengwo is dedicated to enhancing the travel experience through accessible and comprehensive resources.

Nuvaira

Series E in 2019
Nuvaira, Inc. is a medical device company focused on developing innovative treatments for obstructive lung diseases, particularly chronic obstructive pulmonary disease (COPD). The company has created a novel, catheter-based Lung Denervation System designed to address airway nerve hyperactivity, a common issue in patients with COPD and asthma. This minimally invasive procedure targets the parasympathetic nerves of the lungs, aiming to enhance lung function, improve exercise capacity, and elevate the quality of life for affected individuals. Founded in 2008 and headquartered in Minneapolis, Minnesota, Nuvaira was previously known as Holaira, Inc. before rebranding in June 2017.

Schrodinger

Series E in 2019
Schrödinger is a healthcare software company that specializes in computational drug design, serving the biopharmaceutical and biotechnology sectors. Founded in 1990, the company operates through two main segments: Software and Drug Discovery. Its software solutions facilitate drug discovery processes for pharmaceutical and industrial clients, as well as academic and governmental research institutions. In addition to software sales, Schrödinger engages in drug discovery through its own preclinical and clinical programs, often collaborating with other organizations. The company is committed to advancing its computational platform by investing in scientific research and talent, and it has established partnerships and collaborations across more than 70 countries. With a workforce of over 400 employees, Schrödinger continues to influence the life sciences and materials science industries through innovative approaches to drug discovery.

YI Technology

Series D in 2018
YI Technology, the leading international provider of advanced, intelligent imaging technologies, has announced the launch of the industry’s first and only action camera that provides 4K60 video recording with the longest ever recording time.

AoHua

Series D in 2018
Aohua Endoscopy Co., Ltd. is a manufacturer of endoscopy equipment and consumables, offering a range of products including imaging processors, endoscopes, and various accessories. The company specializes in solutions for gastroenterology, respiratory care, ear, nose, and throat (E.N.T) applications, as well as veterinary endoscopy. Founded in 1994, Aohua is headquartered in Shanghai, China, and aims to lead in the innovation of endoscope technology while advancing the field of endoscopic diagnosis and treatment.

Tuhu

Series E in 2018
Tuhu offers same-day or next-day automobile after-sales product delivery and installation services in more than 260 cities across mainland China. The company provides its services via its website, mobile app, call center, and third-party e-commerce platforms.

MicroPoint Bioscience

Series E in 2018
MicroPoint Bioscience, Inc. (微点生物) is a Chinese company dedicated to biochip research and development. The company offers a product series, Lab On a Chip, which is based on micro-electronic mechanical technologies. MicroPoint Biosciences customizes demanded products and services for customers in areas of human health such as medicine, environmental protection, food safety, scientific research, and other application areas. In the area of medicine, MicroPoint Company's bedside immediate diagnosis chip and examination instrument provides low-cost resolutions for early diagnosis and the process monitoring of vascular diseases, tumors, emergency treatments, and operations.

Wacai

Series D in 2018
Wacai is a Chinese mobile app developer and the creator of a personal finance management mobile app. The app has two major functions. One, to serve as a bookkeeping service (launched in 2009) and two, a mutual fund trading feature that was added in July of 2013. Its most recent feature, incorporated in April of 2014, is a credit card manager, which is gaining popularity in the Chinese markets. The app currently has over 40 million users.

Xueba100

Series D in 2018
Xueba100 is an educational platform that caters to K-12 students in China, specializing in providing software and online services designed to assist junior and senior high school students with their studies. The platform offers a "super scholar" feature that allows students to upload images of challenging homework questions and receive detailed answers and procedures. This service leverages advanced technology, including STR Technology and deep learning models, to enhance character recognition and improve the accuracy of responses. In addition to its homework assistance, Xueba100 collaborates with experienced instructors to create customized curricula across various subjects, delivering comprehensive educational resources and test preparation tools to support students' learning needs.

ACEA BIO

Series E in 2018
ACEA Biosciences, Inc. is a biotechnology company based in San Diego, California, specializing in the development and commercialization of advanced microelectronic sensor systems for cell-based assays, drug discovery, and diagnostics. Founded in 2002, ACEA has pioneered real-time, label-free cell-based assay technology, marketed under the xCELLigence brand. Its product lineup includes the x-CELLigence System for various applications in biomedicine and pharmaceuticals, CIM systems for real-time monitoring of cell migration, and several RTCA instruments for cardiotoxicity testing and impedance measurement. The company serves a global customer base of over 800 clients and has contributed to more than 350 peer-reviewed publications. Additionally, ACEA has a Therapeutics Business Unit focusing on oncology drug discovery, leveraging its biosensor technology and a proprietary library of over one million compounds. Currently, ACEA has a program in phase II clinical trials in China, underlining its commitment to innovation in the research and healthcare sectors. The company operates manufacturing facilities in Hangzhou, China, and is a subsidiary of Agilent Technologies, Inc.

Chushou

Series D in 2018
Chushou is a Chinese social networking platform that specializes in live video streaming, primarily focused on mobile gaming. The platform hosts approximately 2.7 million live streaming broadcasters, with around 150,000 active hosts engaging daily. Chushou allows gamers to interact with one another while live streaming their mobile gaming activities, creating a dynamic environment for both broadcasters and viewers. Through its mobile-based services, Chushou facilitates a unique community for gamers, fostering interaction and engagement within the gaming ecosystem.

Mafengwo

Series D in 2017
Beijing Mafengwo Network Technology Co., Ltd. operates a comprehensive travel platform that provides information on both domestic and international travel destinations. Founded in 2006, the company allows users to share their travel experiences through a social networking site, featuring over one million user-generated travel guides and more than five million ratings and reviews. Mafengwo offers a wide range of services, including travel route planning, hotel bookings, and essential travel information such as visa requirements and insurance. The platform also emphasizes user engagement and continuously enhances its features to improve the sharing of travel-related content. With a core product encompassing a vast array of global destinations, Mafengwo has achieved over 100 million downloads of its travel guides and serves millions of users annually. The company has integrated various booking services, partnering with established platforms to streamline the travel planning process. Based in Beijing, Mafengwo is dedicated to enhancing the travel experience through accessible and comprehensive resources.

CEHome

Series D in 2017
Cehome was established in 2009 by the founder and CEO Fan Construction to create armor and armor forum. Since its inception, armored to intentions to serve users and promote industry progress as its mission, committed to using the Internet to promote the development of China's construction machinery industry.

Lagou

Series D in 2017
Lagou.com operates a recruitment website and offers staffing services. The company’s clientele includes Tencent, Baidu, Alibaba Group, SINA, JD.com, Beijing Xiaomi Tech, and Zhaopin.com. Lagou.com was founded in 2013 and is based in Beijing, China.

Mobike

Series E in 2017
Meituan Bike (formerly Mobike) is a Chinese fully station-less bicycle-sharing system. It develops mobile apps for users to find and use bicycles to travel anywhere. Davis Wang Xiao Feng, Hu Wei Wei, and Xia Yi Ping founded Mobike on January 27, 2015, with its headquarters in Beijing, China. Mobike raised $600 million in Series E funding led by Tencent, bringing the firm's fundraising in 2017 alone to nearly US$1 billion in June 2017. It became worth US$3 billion in the same month. Chinese web company Meituan-Dianping acquired Mobike for US$2.7 billion in April 2018. Parent company Meituan-Dianping announced name change from Mobike to Meituan Bike on January 23, 2019 as part of an ongoing integration.

CanSinoBIO

Series E in 2017
CanSino Biologics Inc. is a biotechnology company based in Tianjin, China, focused on the research, development, manufacturing, and commercialization of vaccines. The company is actively developing a range of vaccines, including those for Ebola, meningitis, pertussis, and pneumococcal diseases, with multiple candidates currently in various phases of clinical trials. Notable products under development include the recombinant coronavirus vaccine Ad5-nCov, as well as several preclinical stage vaccines targeting adenovirus, Zika virus, meningitis, shingles, and polio. CanSino collaborates with the National Research Council of Canada to advance COVID-19 vaccine initiatives and has a co-development agreement with Precision NanoSystems to create an mRNA lipid nanoparticle vaccine against COVID-19. Founded in 2009, CanSino aims to meet the unmet medical needs in China and other emerging markets by providing high-quality vaccines at affordable prices.

ByteDance

Series D in 2017
ByteDance is an Internet technology company headquartered in Haidian, China, established in March 2012. The company specializes in creating mobile applications that cater to online media, entertainment, and social networking. ByteDance leverages artificial intelligence and machine learning to personalize content for users, enabling them to discover and engage with creative platforms tailored to their interests. With a robust user base of nearly 200 million daily active users, each spending an average of one hour daily on its products, ByteDance fosters connections between people and information. Its portfolio includes popular applications such as Topbuzz, Flipagram, and various user-generated content short-form video platforms, which have gained significant traction among mobile users globally. The company also maintains offices in the USA and Japan, enhancing its international presence.

Zhihu

Series D in 2017
Zhihu (知乎) is a Chinese socialized website for questions and answers. It differs from traditional online question and answer forums by enabling users to obtain information through questions that provoke the opinions and views from answerers as individuals. The number of registered users on Zhihu has surpassed 300,000 by the end of January 2012. Zhihu was founded in 2011.

CooTek

Series D in 2017
CooTek (NYSE: CTK), founded in 2008, listed on NYSE on September 28th, 2018, is a global and fast-growing mobile internet company that develops innovative mobile apps and artificial intelligence technology. With a massive global user base, CooTek aims to empower users to express themselves and enjoy relevant content seamlessly. CooTek’s flagship mobile app, TouchPal Keyboard, uses unparalleled technology to provide the best input experience to both Android and iPhone users. CooTek has also developed many content-rich apps, spanning across 5 selected verticals including fitness, lifestyle, healthcare, news and short videos, and entertainment. In September 2018, CooTek’s global products reached an average of 213.7 million monthly active users around the world. Headquartered in Shanghai, CooTek offices can be found in Silicon Valley, Beijing, Taipei, Guangzhou, and Shenzhen. Today, CooTek has over 170 patent applications and granted patents worldwide and continually pursue excellence in technology innovation and intellectual property development. CooTek has also established its own big data development center and AI lab in Silicon Valley. Many academic papers written by CooTek have been used in discussions at world-renowned big data and AI conferences such as AAAI, KDD and CIKM.

Mobike

Series D in 2017
Meituan Bike (formerly Mobike) is a Chinese fully station-less bicycle-sharing system. It develops mobile apps for users to find and use bicycles to travel anywhere. Davis Wang Xiao Feng, Hu Wei Wei, and Xia Yi Ping founded Mobike on January 27, 2015, with its headquarters in Beijing, China. Mobike raised $600 million in Series E funding led by Tencent, bringing the firm's fundraising in 2017 alone to nearly US$1 billion in June 2017. It became worth US$3 billion in the same month. Chinese web company Meituan-Dianping acquired Mobike for US$2.7 billion in April 2018. Parent company Meituan-Dianping announced name change from Mobike to Meituan Bike on January 23, 2019 as part of an ongoing integration.

Shenogen Pharma Group

Series D in 2017
Shenogen Pharma Group is a drug discovery and development company.

OneAPM

Series D in 2016
OneAPM is an IT operation and maintenance management software and service provider. Founded in 2008 in Beijing, the company has always been adhering to the corporate mission of “making the operation and maintenance more intelligent” and is committed to providing integrated intelligent operation and maintenance solutions for enterprise users in China.

CooTek

Series D in 2016
CooTek (NYSE: CTK), founded in 2008, listed on NYSE on September 28th, 2018, is a global and fast-growing mobile internet company that develops innovative mobile apps and artificial intelligence technology. With a massive global user base, CooTek aims to empower users to express themselves and enjoy relevant content seamlessly. CooTek’s flagship mobile app, TouchPal Keyboard, uses unparalleled technology to provide the best input experience to both Android and iPhone users. CooTek has also developed many content-rich apps, spanning across 5 selected verticals including fitness, lifestyle, healthcare, news and short videos, and entertainment. In September 2018, CooTek’s global products reached an average of 213.7 million monthly active users around the world. Headquartered in Shanghai, CooTek offices can be found in Silicon Valley, Beijing, Taipei, Guangzhou, and Shenzhen. Today, CooTek has over 170 patent applications and granted patents worldwide and continually pursue excellence in technology innovation and intellectual property development. CooTek has also established its own big data development center and AI lab in Silicon Valley. Many academic papers written by CooTek have been used in discussions at world-renowned big data and AI conferences such as AAAI, KDD and CIKM.

ACEA BIO

Series E in 2016
ACEA Biosciences, Inc. is a biotechnology company based in San Diego, California, specializing in the development and commercialization of advanced microelectronic sensor systems for cell-based assays, drug discovery, and diagnostics. Founded in 2002, ACEA has pioneered real-time, label-free cell-based assay technology, marketed under the xCELLigence brand. Its product lineup includes the x-CELLigence System for various applications in biomedicine and pharmaceuticals, CIM systems for real-time monitoring of cell migration, and several RTCA instruments for cardiotoxicity testing and impedance measurement. The company serves a global customer base of over 800 clients and has contributed to more than 350 peer-reviewed publications. Additionally, ACEA has a Therapeutics Business Unit focusing on oncology drug discovery, leveraging its biosensor technology and a proprietary library of over one million compounds. Currently, ACEA has a program in phase II clinical trials in China, underlining its commitment to innovation in the research and healthcare sectors. The company operates manufacturing facilities in Hangzhou, China, and is a subsidiary of Agilent Technologies, Inc.

Qiniu

Series D in 2016
Shanghai Qiniu Information Technologies Co., Ltd. is a prominent enterprise cloud service provider based in Shanghai, China, founded in 2003. The company specializes in Internet data storage services and has developed QBox, a free storage solution that allows users to access files via web, PC, and mobile devices. Qiniu Cloud focuses on cloud computing, data intelligence, and visual intelligence, offering a comprehensive suite of services that includes intelligent video cloud solutions, CDN integration, object storage, and big data capabilities. With over one million enterprise-level clients, Qiniu Cloud plays a significant role in supporting 80% of the Internet users in China. The company aims to empower various industries with advanced cloud technology, addressing the emerging opportunities presented by artificial intelligence and the 5G era.

Shenogen Pharma Group

Series D in 2015
Shenogen Pharma Group is a drug discovery and development company.

Mitralign

Series E in 2015
Mitralign is a privately held company based in a suburb of Boston, Massachusetts, focused on developing a catheter-based technology for the treatment of functional mitral regurgitation. The company has created an innovative system that mimics surgical annuloplasty by delivering surgical implants directly into the mitral annulus via a catheter. This process involves cinching the implants together to decrease the size of the mitral valve annulus and the valve opening. Mitralign's technology aims to provide a less invasive option for managing this life-threatening cardiac condition, enabling healthcare providers to effectively treat symptomatic functional mitral regurgitation through tissue-plication. The company is supported by prominent venture capitalists and has attracted investments from major cardiovascular device firms.

LanzaTech

Series D in 2014
LanzaTech, Inc. is a carbon recycling company based in Skokie, Illinois, with additional offices in Roselle, Illinois; Shanghai, China; and Gurgaon, India. Founded in 2005, the company specializes in producing fuel ethanol from renewable non-food resources, including industrial flue gases and waste gases generated from the gasification of municipal solid waste and biomass. LanzaTech's innovative technology enables the conversion of carbon emissions from sources like steel mills into valuable products, such as sustainable fuels and chemicals, thus contributing to a circular carbon economy. By recycling carbon from various waste streams, LanzaTech aims to reduce global CO2 emissions significantly and displace a substantial portion of crude oil use, ultimately transforming waste carbon into essential building blocks for consumer goods.

MOGU

Series D in 2014
MOGU is an consumer platform aimed towards women, achieved through e-commerce, social media, influencers and content driven services. Their content covers all areas of the fashion world and they have a huge range of age groups and interest covered through their numerous apps and platform. MOGU Inc. is a destination of fashion. With various kinds of fashion content and abundant fashion products, MOGU Inc. allows people to discover and share fashion trends while fully enjoying high-quality shopping experience. In 2011, MOGU Inc. launched fashion platform under the Mogujie brand . In 2016, the merger of Mogujie and Meilishuo was completed.Currently, MOGU Inc.'s online platform includes Mogujie.com and Meilishuo.com websites, mogujie mobile app, Meilishuo mobile app, Uni mobile app and several WeChat Mini programs.

Crown Bioscience

Series D in 2014
CrownBio is a Cutting Edge Translational Technology Company Making Precision Medicine a Reality CrownBio brings clarity to drug discovery around the world by helping biopharmaceutical companies solve some of today's most pressing challenges in oncology, cardiovascular, and metabolic disease Drug Discovery. Their premier Translational Platforms for cancer and metabolic disease help our clients accelerate their new drug development programs. CrownBio develops world-leading preclinical efficacy models and provides both in vitro and in vivo testing services and preclinical research products. They are a global company with facilities across the world in the United States, United Kingdom, China, and Taiwan.

VANCL

Series G in 2014
VANCL retails apparel, accessories, footwear, luggage, and textiles online. It markets shirts, T-shirts, trousers, pants, shorts, dresses, silk ties, belts, caps, scarves, sunglasses, shoes, sandals, socks, handbags, luggage, backpacks, bedsheets, and towels. VANCL has both online and physical stores. Chen Nian founded it in 2007, with its headquarters in Beijing in China.

VANCL

Series G in 2013
VANCL retails apparel, accessories, footwear, luggage, and textiles online. It markets shirts, T-shirts, trousers, pants, shorts, dresses, silk ties, belts, caps, scarves, sunglasses, shoes, sandals, socks, handbags, luggage, backpacks, bedsheets, and towels. VANCL has both online and physical stores. Chen Nian founded it in 2007, with its headquarters in Beijing in China.

Novast

Series D in 2011
Novast is focused on the research, development and manufacture of value-added generic drugs with release control and other dosage types, and sells them into US pharmaceutical market cooperating with US leading channel. Cooperating with US sales channels and original development enterprises, it is the first pharmaceutical enterprise in China selling pharmaceutical products into US local market. Novast Pharmaceutical Company owns cGMP manufacturing facilities covering18, 000 square meters, and its management team has experiences of applying more than 100 generic drug patents in U.S., and many years of working experience in U.S. Novast also independently researches and develops multiple drug-delivery and dosage type technology.

VANCL

Series F in 2011
VANCL retails apparel, accessories, footwear, luggage, and textiles online. It markets shirts, T-shirts, trousers, pants, shorts, dresses, silk ties, belts, caps, scarves, sunglasses, shoes, sandals, socks, handbags, luggage, backpacks, bedsheets, and towels. VANCL has both online and physical stores. Chen Nian founded it in 2007, with its headquarters in Beijing in China.

CITIC Pharmaceutical

Series D in 2009
CITIC Pharmaceutical Co., Ltd. (中信医药) is a pharmaceutical service provider that supplies medicine and related consumables to hospitals. It is a large pharmaceutical operation enterprise integrating medicines supply to hospitals, cross-regional commercial distribution, vaccine sale, medical instruments and consumables sale, and medicine retailing service. In recent years, it has become a pharmaceutical service provider in the supply chain with multiple customized integration service. CITIC Pharmaceutical, which is a subsidiary of CITIC Group, was transformed to a joint venture in 2007. It is invested by China Health System whose holding company is Bioveda China fund and CITIC Investment Holdings Ltd.

ChinaCache

Series D in 2009
ChinaCache is a prominent Chinese provider of content delivery networks and cloud-based services, established in 1998. The company caters to a diverse range of clients, including small and large enterprises, luxury brands, e-commerce platforms, banking institutions, online gaming, and media organizations. With a robust infrastructure that includes over 400 service nodes in more than 120 major cities across China, ChinaCache offers a total network capacity exceeding 1000Gbps. The company maintains interconnections with all major telecommunications carriers and local internet service providers in Mainland China, enabling it to enhance online services and user experiences for its clients. All of ChinaCache's revenue is generated within the People's Republic of China, underscoring its focus on the domestic market.

VANCL

Series D in 2008
VANCL retails apparel, accessories, footwear, luggage, and textiles online. It markets shirts, T-shirts, trousers, pants, shorts, dresses, silk ties, belts, caps, scarves, sunglasses, shoes, sandals, socks, handbags, luggage, backpacks, bedsheets, and towels. VANCL has both online and physical stores. Chen Nian founded it in 2007, with its headquarters in Beijing in China.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.